Results 131 to 140 of about 7,965 (181)

The role of arachidonic acid metabolites in the subtype classification and pathogenesis of primary aldosteronism. [PDF]

open access: yesiScience
You M   +14 more
europepmc   +1 more source

Association between serum uric acid levels and primary aldosteronism. [PDF]

open access: yesBMC Nephrol
Zhao X   +7 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Primary aldosteronism

Journal of Endocrinological Investigation, 1995
The basic clinical pathophysiology of primary aldosteronism (PAL) was described by Conn in terms of autonomous production of aldosterone, secondary suppression of renin and development of hypertension with hypokalaemic alkalosis. Conn recognised a normokalaemic form of the syndrome and suggested that it might masquerade as essential hypertension and be
W R, Litchfield, R G, Dluhy
openaire   +7 more sources

Primary aldosteronism

Journal of Surgical Oncology, 2009
AbstractPrimary aldosteronism is the most common form of secondary hypertension. Case detection is based on an abnormal plasma aldosterone:plasma renin activity ratio and the diagnosis must be confirmed with an aldosterone suppression test. Subtype differentiation should be performed using adrenal venous sampling.
openaire   +4 more sources

Primary aldosteronism

Current Cardiology Reports, 2007
Primary aldosteronism is one of the few potentially curable forms of hypertension. This article highlights recent advances in the pathophysiology, diagnosis, and treatment of this relatively common secondary form of hypertension. These topics include the recognition that this disorder is more prevalent than previously assumed, the identification of ...
Richard J, Auchus, Fiemu E, Nwariaku
openaire   +2 more sources

Primary aldosteronism

Trends in Cardiovascular Medicine, 2016
In 1955 Dr Jerome Conn first documented primary aldosteronism (PA). Since then, screening, diagnosis and treatment have developed, in the process both refining and complicating management. Currently, screening requires 4-6 weeks of lead-up, including major changes in antihypertensive therapy, followed by a blood draw for plasma aldosterone ...
openaire   +3 more sources

PRIMARY ALDOSTERONISM

Australasian Annals of Medicine, 1957
SUMMARYA female patient, aged thirty‐one years, suffering from primary aldosteronism due to adrenal adenoma (Conn's syndrome) is described. She presented with hypertension of the order of 240/120 millimetres of mercury associated with weakness, polyuria up to five litres a day, and an electrocardiogram showin;STdepression and prominentUwaves in various
B, HUDSON, A J, BARNETT, J, BORNSTEIN
openaire   +2 more sources

Primary aldosteronism

Best Practice & Research Clinical Endocrinology & Metabolism, 2003
Approaching the fiftieth year since its original description, primary aldosteronism is now thought to be the commonest potentially curable and specifically treatable form of hypertension. Correct identification of patients with primary aldosteronism requires that the effects of time of day, posture, dietary sodium intake, potassium levels and ...
Stowasser, Michael, Gordon, Richard D.
openaire   +5 more sources

Home - About - Disclaimer - Privacy